Ns Pharma, Inc.

NJ · United States · Reporting entity ID 100000616811

Total reported 2019–2025

$4.58M

#741 of 2,960 reporting companies — 0% of all reported industry payments

$586K in general payments across 1,808 records, plus $3.99M in research funding across 899 records.

How it breaks down

General payments $585,600

Research funding $3,990,969

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.